Skip to main content
Contact Us
search

Barnabie Agatep

Author Biography

Barnabie.Agatep@inovalon.com
Connect on LinkedIn

Barnabie Agatep, MPH

Director, Health Economics and Outcomes Research

Barnabie advises clients on health economic and outcomes research initiatives that support product commercialization and demonstrate client product/service value. Barnabie also has experience conducting retrospective database analysis and evaluating quality measures for specific therapeutic areas.

Prior to joining Inovalon, Barnabie served as a senior manager in Health Economics and Outcomes Research at the Medco Research Institute and as a research associate for Pfizer Inc., Global Outcomes Research. At Medco, Barnabie developed economic models and conducted retrospective research analysis to illustrate the cost-effectiveness and value of pharmacogenomics and personalized medicine. At Pfizer, Barnabie assisted in drafting product dossiers, pharmacoeconomics research analysis, and other outcomes research initiatives in support of launching pre-existing urology products.

Barnabie has an MPH in epidemiology from the University of Medicine and Dentistry of New Jersey School of Public Health and a BS in public health from The Richard Stockton College of New Jersey.

Authored Content

Filter

May 3, 2023
Poster Presentation

An Assessment of the Direct and Indirect Costs of Bladder Cancer Preceding and Following a Cystectomy: A Real-World Evidence Study

Tkacz J.P., Ireland I., Norris K., Agatep B., Forman C., Ellis L., Khaki A.
This study estimated the direct and indirect costs of bladder cancer prior to and following cystectomy.
Read More
September 9, 2022
Presentation

Characteristics and Long-Term Health Economic Outcomes of Female Medicare Beneficiaries with Fragility Fracture Receiving Skilled Nursing Facility Care

Teigland C, Pulungan Z, Schinkel J, Agatep B, Yeh E
Accepted for presentation at American Society for Bone & Mineral Research (ASBMR) 2022. Findings available upon request. Contact us for more information.
Read More
May 31, 2022
Presentation

Characteristics and Treatment Patterns in Medicare Patients Newly Diagnosed with Schizophrenia with Traditional Fee-For Service Versus Private Medicare Advantage Insurance Coverage

Teigland C, Kim S, Mohammadi I, Agatep B, Boskovic DH
Accepted for presentation at American Society of Clinical Psychopharmacology 2022 Annual Meeting. Findings available upon request. Contact us for more information.
Read More
May 15, 2022
Presentation

Treatment Patterns in Patients Newly Diagnosed with Schizophrenia with Commercial Versus Medicaid Insurance Coverage

Teigland C, Kim S, Mohammadi I, Agatep B, Boskovic DH
Schizophrenia is a serious mental disorder that requires lifelong treatment. Early treatment can help get symptoms under control before serious complications develop (e.g., suicide, anxiety disorder, aggressive behavior, depression, alcohol/drug abuse, inability to work, financial and health/medical problems). This research evaluated treatment patterns in patients newly diagnosed with schizophrenia in two populations with commercial versus Medicaid insurance.
Read More
May 15, 2022
Presentation

Treatment Patterns in Patients Newly Diagnosed with Schizophrenia with Commercial Versus Medicaid Insurance Coverage

Teigland C, Kim S, Mohammadi I, Agatep B, Boskovic DH
Accepted for presentation at ISPOR 2022. Findings available upon request. Contact us for more information.
Read More
April 6, 2022
Presentation

Impact of Social Determinants of Health (SDOH) and Specialist Care on Healthcare Resource Utilization (HRU) and Costs in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Kilgore K, Pareja K, Teigland C, Mohammadi I, Frank L, Agatep B, Nunna S
Accepted for presentation at National Kidney Foundation Spring Clinical Meeting 2022. Findings available upon request. Contact us for more information.
Read More
March 29, 2022
Presentation

Social Determinants of Health, Healthcare Resource Utilization, and Costs Among Patients with Schizophrenia by Type of Insurance

Teigland C, Kim S, Mohammadi I, Agatep B, Boskovic DH
Accepted for presentation at AMCP 2022. Findings available upon request. Contact us for more information.
Read More
October 29, 2021
Presentation

Medicare beneficiaries with serious mental illness (SMI) have high prevalence of social determinants of health (SDOH)

Teigland C, Kim S, Mohammadi I, Agatep B, Boskovic DH
Accepted for presentation at Psych Congress 2021. Findings available upon request. Contact us for more information.
Read More